Hunan Warrant Pharmaceutical Co.,Ltd (SHA:688799)
China flag China · Delayed Price · Currency is CNY
42.47
-0.35 (-0.82%)
May 14, 2025, 2:45 PM CST

SHA:688799 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
4,0173,9284,5912,9863,862-
Upgrade
Market Cap Growth
-22.98%-14.43%53.75%-22.69%--
Upgrade
Enterprise Value
3,8713,6964,1842,3763,094-
Upgrade
Last Close Price
42.8241.8847.9230.4738.54-
Upgrade
PE Ratio
27.6323.9121.7216.3324.02-
Upgrade
PS Ratio
2.922.783.202.313.37-
Upgrade
PB Ratio
2.142.152.601.802.61-
Upgrade
P/TBV Ratio
2.452.482.842.012.72-
Upgrade
P/FCF Ratio
--42.24125.46170.68-
Upgrade
P/OCF Ratio
32.0627.6221.4119.1833.66-
Upgrade
EV/Sales Ratio
2.812.622.921.842.70-
Upgrade
EV/EBITDA Ratio
21.1917.7715.8511.0116.27-
Upgrade
EV/EBIT Ratio
34.6226.5720.6214.2319.85-
Upgrade
EV/FCF Ratio
-23.14-38.5099.86136.75-
Upgrade
Debt / Equity Ratio
0.070.070.01---
Upgrade
Debt / EBITDA Ratio
0.750.570.06---
Upgrade
Debt / FCF Ratio
--0.16---
Upgrade
Asset Turnover
0.580.610.690.680.841.07
Upgrade
Inventory Turnover
1.371.411.461.321.311.38
Upgrade
Quick Ratio
1.492.152.772.993.410.97
Upgrade
Current Ratio
3.873.424.014.234.651.89
Upgrade
Return on Equity (ROE)
6.68%7.73%11.27%11.05%15.01%23.85%
Upgrade
Return on Assets (ROA)
2.95%3.75%6.06%5.48%7.17%10.54%
Upgrade
Return on Capital (ROIC)
3.60%4.67%7.37%6.65%9.10%15.36%
Upgrade
Return on Capital Employed (ROCE)
5.30%6.80%11.00%9.70%10.10%21.40%
Upgrade
Earnings Yield
3.62%4.18%4.60%6.12%4.16%-
Upgrade
FCF Yield
-4.17%-2.33%2.37%0.80%0.59%-
Upgrade
Dividend Yield
1.45%1.43%1.88%2.95%1.82%-
Upgrade
Payout Ratio
59.65%52.55%39.96%35.92%-24.24%
Upgrade
Buyback Yield / Dilution
0.30%0.03%-0.18%-17.21%-13.60%-0.13%
Upgrade
Total Shareholder Return
1.75%1.46%1.69%-14.26%-11.79%-0.13%
Upgrade
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.